³Ô¹Ï±¬ÁÏ

Contact Sales +44 800 208 8103

Regions

Europe

EN | DE | ES | FR | IT

North America

°ä³ó¾±²Ô²¹&²Ô²ú²õ±è;Öйú

´³²¹±è²¹²Ô&²Ô²ú²õ±è;ÈÕ±¾

Asia Pacific

Korea

Latin America

PORTUGUESE | SPANISH

Industries

Life Sciences

MedTech

³Ô¹Ï±¬ÁÏ
Clinical
Regulatory
Safety
Quality
Medical
Commercial
Data
Vault AI
Industries
Demo Center
VEEVA Development Cloud
³Ô¹Ï±¬ÁÏ Clinical Platform
Clinical Operations
³Ô¹Ï±¬ÁÏ eTMF

Stay inspection ready

³Ô¹Ï±¬ÁÏ CTMS

Manage trials end-to-end

³Ô¹Ï±¬ÁÏ Payments

Pay clinical research sites faster

³Ô¹Ï±¬ÁÏ Study Startup

Accelerate site activation

³Ô¹Ï±¬ÁÏ RTSM

Randomization and supply management

³Ô¹Ï±¬ÁÏ Site Connect

Automate information sharing

³Ô¹Ï±¬ÁÏ Study Training

Streamline and automate training

³Ô¹Ï±¬ÁÏ Disclosures

Centralize clinical trial disclosures

³Ô¹Ï±¬ÁÏ OpenData Clinical

Provide investigator and site data

Clinical Data
³Ô¹Ï±¬ÁÏ EDC

Collect and verify site data

³Ô¹Ï±¬ÁÏ DQS

Aggregate and clean study data

³Ô¹Ï±¬ÁÏ eCOA

Capture patient data

Learn About the Patient Experience
Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
³Ô¹Ï±¬ÁÏ Connections Hub
VEEVA Development Cloud
³Ô¹Ï±¬ÁÏ RIM
³Ô¹Ï±¬ÁÏ Registrations

Track global registrations

³Ô¹Ï±¬ÁÏ Submissions

Plan and manage submissions

³Ô¹Ï±¬ÁÏ Submissions Publishing

Publish to health authorities

³Ô¹Ï±¬ÁÏ Submissions Archive

Access submissions history

Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
³Ô¹Ï±¬ÁÏ Connections Hub
VEEVA QUALITY CLOUD
Quality Assurance
³Ô¹Ï±¬ÁÏ QMS

Manage all quality processes in one place

³Ô¹Ï±¬ÁÏ QualityDocs

Gain control of GxP documents

³Ô¹Ï±¬ÁÏ Validation Management

Manage and execute paperless validation

³Ô¹Ï±¬ÁÏ Batch Release

Speed release decisions with confidence

³Ô¹Ï±¬ÁÏ Product Surveillance

Simplify postmarket surveillance for medical devices

³Ô¹Ï±¬ÁÏ Station Manager

Deliver right content to the right station

Training
³Ô¹Ï±¬ÁÏ Training

Ensure role-based qualification and compliance

Quality Control
³Ô¹Ï±¬ÁÏ LIMS

Optimize QC labs to increase efficiency

Health and Safety
³Ô¹Ï±¬ÁÏ EHS

Manage environmental, health, and safety processes

Are you a Contract Services Organization? Learn More
Are you a Generics Organization? Learn more
Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
³Ô¹Ï±¬ÁÏ Connections Hub
VEEVA Development Cloud
³Ô¹Ï±¬ÁÏ Safety Suite
³Ô¹Ï±¬ÁÏ Safety

Adverse Event management

³Ô¹Ï±¬ÁÏ SafetyDocs

Manage safety content

³Ô¹Ï±¬ÁÏ Safety Workbench

Advanced reporting and analysis?

³Ô¹Ï±¬ÁÏ Safety Signal

Signal detection and management

Are you an emerging or clinical biotech? Learn More
Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
³Ô¹Ï±¬ÁÏ Connections Hub
Are you a CRO? Learn more
³Ô¹Ï±¬ÁÏ Medical Suite
Operations
³Ô¹Ï±¬ÁÏ Publications

Plan, author, and manage publications

³Ô¹Ï±¬ÁÏ MedComms

Centralize and scale medical content

³Ô¹Ï±¬ÁÏ MedInquiry

Streamline inquiry intake and fulfillment

Insights
³Ô¹Ï±¬ÁÏ Link Medical Insights

Accelerate insights from capture to action

Measuring Medical Impact
Reimagine Medical Engagement
Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
³Ô¹Ï±¬ÁÏ Connections Hub
Engagement
Medical CRM

Drive high-impact scientific exchange

³Ô¹Ï±¬ÁÏ Link Key People

Get deep data on KOLs and their ecosystems

³Ô¹Ï±¬ÁÏ Link Workflow

Manage KOL engagement workflows

VEEVA COMMERCIAL SOLUTIONS
Commercial Evidence™

Transform field and digital interactions into actionable insights

Software
CRM Suite

Coordinated agentic engagement across channels

Campaign Manager

Synchronized sales and marketing

Events Management

Live, virtual, and hybrid events

Align

Territory, roster, and engagement planning

Content

Compliant content at scale

Marketing Analytics (U.S.-specific)

Campaign measurement, targeting, and insights

Network MDM

Standardized master data management

Data Science and Analytics Platform

Integrated commercial data for faster insights

Data
Global Reference Data

Complete HCP and HCO profiles

Global HCP Data

HCP access data

Global Deep Data

KOL profiles and key account data

U.S. Performance Data (U.S.-specific)

Patient and prescriber data

Services
Business Consulting

Strategic advisory services


By Need
Achieve Agentic Commercial
Deepen Your Customer Insights
Agentic AI for MLR
 
Increase Omnichannel Impact
Drive Launch Excellence
VEEVA DATA CLOUD
Global Reference Data
³Ô¹Ï±¬ÁÏ OpenData Commercial

Complete HCP and HCO profiles

³Ô¹Ï±¬ÁÏ OpenData Clinical

Accurate site and investigator data

Global HCP Data
³Ô¹Ï±¬ÁÏ HCP Access

HCP access data

Global Deep Data
³Ô¹Ï±¬ÁÏ Link Key People

Deep data on KOLs

³Ô¹Ï±¬ÁÏ Link Key Accounts

Deep data on key accounts

U.S. Performance Data (U.S.-specific)
³Ô¹Ï±¬ÁÏ Compass (U.S.-specific)

Patient and prescriber data

Services
³Ô¹Ï±¬ÁÏ Analytics

Strategic advisory services

FOR VAULT PLATFORM
& VEEVA APPLICATIONS
Vault AI
Agentic AI

Built into Vault Platform

AI Agents

Deploy standard and custom agents

Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
Industries
Pharma & Biotech

R&D, quality, medical, and commercial solutions

Consumer Health

Solutions from clinical to commercial

Animal Health

Tailored applications for animal health

MedTech

Streamline content and data management

Demo Center
AI (³Ô¹Ï±¬ÁÏ AI)

Clinical Operations

Clinical Data

Regulatory

Safety

Development Cloud

Quality

Commercial

Medical

Data

Services
Services
Business Consulting
Analytics
Partners
Services Partners
Product Partners
AI Partners
Content Partners
CRO Partners
Data Partners
Customers
Resources
Events
About ³Ô¹Ï±¬ÁÏ
About ³Ô¹Ï±¬ÁÏ
Leadership
Public Benefit Corporation 
Corporate Citizenship
Diversity at ³Ô¹Ï±¬ÁÏ 
Partners 
Trust
Recent University Graduates 
News
Announcements
Press Coverage
³Ô¹Ï±¬ÁÏ Blog
Contact Us
  • Home
  • Contact
  • ³Ô¹Ï±¬ÁÏ
    • Clinical Solutions
      • Development Cloud
      • ³Ô¹Ï±¬ÁÏ Clinical Platform
      • Clinical Operations
      • ³Ô¹Ï±¬ÁÏ eTMF
      • ³Ô¹Ï±¬ÁÏ CTMS
      • ³Ô¹Ï±¬ÁÏ Payments
      • ³Ô¹Ï±¬ÁÏ Study Startup
      • ³Ô¹Ï±¬ÁÏ RTSM
      • ³Ô¹Ï±¬ÁÏ Site Connect
      • ³Ô¹Ï±¬ÁÏ Study Training
      • ³Ô¹Ï±¬ÁÏ Disclosures
      • ³Ô¹Ï±¬ÁÏ OpenData Clinical
      • Clinical Data
      • ³Ô¹Ï±¬ÁÏ EDC
      • ³Ô¹Ï±¬ÁÏ DQS
      • ³Ô¹Ï±¬ÁÏ eCOA
      • Patient Experience
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
      • Demo Center
    • Regulatory Solutions
      • Development Cloud
      • ³Ô¹Ï±¬ÁÏ RIM
      • ³Ô¹Ï±¬ÁÏ Registrations
      • ³Ô¹Ï±¬ÁÏ Submissions
      • ³Ô¹Ï±¬ÁÏ Submissions Publishing
      • ³Ô¹Ï±¬ÁÏ Submissions Archive
      • Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
      • Demo Center
    • Safety Solutions
      • Development Cloud
      • ³Ô¹Ï±¬ÁÏ Safety Suite
      • ³Ô¹Ï±¬ÁÏ Safety
      • ³Ô¹Ï±¬ÁÏ SafetyDocs
      • ³Ô¹Ï±¬ÁÏ Safety Workbench
      • ³Ô¹Ï±¬ÁÏ Safety Signal
      • Vault Platform
      • Demo Center
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Quality Solutions
      • Quality Cloud
      • Quality Assurance
      • ³Ô¹Ï±¬ÁÏ QMS
      • ³Ô¹Ï±¬ÁÏ QualityDocs
      • ³Ô¹Ï±¬ÁÏ Validation Management
      • ³Ô¹Ï±¬ÁÏ Batch Release
      • ³Ô¹Ï±¬ÁÏ Product Surveillance
      • ³Ô¹Ï±¬ÁÏ Station Manager
      • Training
      • ³Ô¹Ï±¬ÁÏ Training
      • Quality Control
      • ³Ô¹Ï±¬ÁÏ LIMS
      • Health and Safety
      • ³Ô¹Ï±¬ÁÏ EHS
      • Vault Platform
      • Demo Center
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Medical Suite
      • Operations
      • ³Ô¹Ï±¬ÁÏ Publications
      • ³Ô¹Ï±¬ÁÏ MedComms
      • ³Ô¹Ï±¬ÁÏ MedInquiry
      • Engagement
      • Medical CRM
      • ³Ô¹Ï±¬ÁÏ Link Key People
      • ³Ô¹Ï±¬ÁÏ Link Workflow
      • Insights
      • ³Ô¹Ï±¬ÁÏ Link Medical Insights
      • Measuring Medical Impact
      • Reimagine Medical Engagement
      • Learn About ³Ô¹Ï±¬ÁÏ Vault Platform
      • ³Ô¹Ï±¬ÁÏ Connections Hub
    • Commercial Solutions
      • Commercial Evidence?
      • Software
      • CRM Suite
      • Campaign Manager
      • Service Center
      • Events Management
      • Align
      • Content
      • Network MDM
      • Data Science and Analytics Platform
      • Marketing Analytics (U.S.-specific)
      • Data
      • Global Reference Data
      • Global HCP Data
      • Global Deep Data
      • U.S. Performance Data (U.S.-specific) 
      • Services
      • Business Consulting
      • Demo Center
    • Data Solutions
      • ³Ô¹Ï±¬ÁÏ Data Cloud
      • Global Reference Data
      • ³Ô¹Ï±¬ÁÏ OpenData Commercial
      • ³Ô¹Ï±¬ÁÏ OpenData Clinical
      • Global HCP Data
      • ³Ô¹Ï±¬ÁÏ HCP Access
      • Global Deep Data
      • ³Ô¹Ï±¬ÁÏ Link Key People
      • ³Ô¹Ï±¬ÁÏ Link Key Accounts
      • U.S. Performance Data
        (U.S.-specific)
      • ³Ô¹Ï±¬ÁÏ Compass (U.S.-specific) 
      • Services
      • ³Ô¹Ï±¬ÁÏ Analytics
      • Demo Center
    • Vault AI
      • Vault AI
      • Agentic AI
      • AI Agents
      • Vault Platform
    • Industries
      • Pharma & Biotech
      • Consumer Health
      • Animal Health
      • MedTech
  • Services
    • Services Overview
    • Business Consulting
    • Analytics
    • ³Ô¹Ï±¬ÁÏ Partners
  • Customers
  • Resources
  • Events
  • About ³Ô¹Ï±¬ÁÏ
    • Leadership
    • Public Benefit Corporation
    • Corporate Citizenship
    • Diversity at ³Ô¹Ï±¬ÁÏ
    • Partners
    • Trust
    • Recent University Graduates
    • News
    • ³Ô¹Ï±¬ÁÏ Blog
    • Contact Us
    •  
Industry Report

³Ô¹Ï±¬ÁÏ Pulse Field Trends Report

Download PDF
Table of Contents

Pre-Launch Field Medical Education Leads to 1.5x Increase in Treatment Adoption

70% of KOLs engage with only one biopharma, as traditional planning misses most experts

For the first time, the biopharma industry has clear data demonstrating the impact of field medical on clinical practice in a launch setting. A new analysis of migraine products shows that disease state education by field medical with key opinion leaders (KOLs) before launch is associated with 1.5 times greater treatment adoption1 across that healthcare organization (HCO) over the first six months post-launch.

Despite this clear connection between scientific engagement and treatment adoption, new data also shows most KOLs are underserved by field medical. ³Ô¹Ï±¬ÁÏ Pulse data reveals that 70% of KOLs engage with only one biopharma, severely limiting scientific exchange, medical insights, and potential treatment adoption.

The industry lacks a standard, data-driven approach to identifying, prioritizing, and engaging KOLs. But companies like Lundbeck are combining real-time customer intelligence and CRM data to create a new engagement model.

¡°The right data is foundational to our engagement strategy. As we prepared for the launch of new treatments, this data- driven approach helped us build the right relationships and focus our resources where they will have the greatest scientific impact,¡± said Christine Castro, director, medical affairs excellence at Lundbeck.

Ensure your field medical team is creating the impact that matters most with ³Ô¹Ï±¬ÁÏ Business Consulting¡¯s in-depth analysis.

Thank you,

Dan Rizzo

Global Head of ³Ô¹Ï±¬ÁÏ Business Consulting


Field Medical Has a Significant Impact on Launch Success

Medical science liaison (MSL) engagement with KOLs before product launch, either in person or via video, results in 1.5 times greater treatment adoption across the HCO within the first six months of launch, compared to HCOs whose KOLs were not engaged.2 This early education by MSLs has a lasting impact, as new treatment starts sustain at 1.3 times greater 18 to 24 months after product launch. These results show what biopharmas have long understood but were not able to accurately measure.

Despite this impact, ³Ô¹Ï±¬ÁÏ Pulse data shows that investment in medical field force size over the last 12 months has remained flat. HCPs, meanwhile, are overwhelmingly asking for more interactions ¨C but underused by biopharma.

Despite Demand, 70% of KOLs Engage With Only One Biopharma

MSLs spend significant time with the KOLs they engage. But, while the depth of individual connections may be substantial, the breadth of KOL engagement is not. New ³Ô¹Ï±¬ÁÏ Pulse and ³Ô¹Ï±¬ÁÏ Link data shows that nearly 70% of KOLs only interact with one company¡¯s field medical team.3

Further, 30% of global experts, as identified in ³Ô¹Ï±¬ÁÏ Link Key People, have no recorded interaction with MSLs at all.4 Whether medical affairs teams miss KOLs in mapping exercises or fail to record interactions, the result is the same ¨C measuring the impact and connecting it to other insights across the organization is impossible.

The way MSLs select KOLs during planning contributes to this problem:

  • Selection methods can be highly biased, especially toward traditional experts
  • Prioritization methods do not reflect true KOL influence
  • Narrow feedback loops limit medical insights and engagement with a broader scientific audience

Identify and Prioritize High-Impact KOLs With Industry Data

Real-time, connected data can broaden access to the right scientific experts as well as generate and share insights across the organization quickly and effectively. By using a data-driven approach, MSLs at one top pharma company improved scientific engagement strategy with medical experts:

Data alone does little, however. The best strategy ingests new data about KOLs quickly, prioritizes engagement based on KOL influence, and drives medical insights back into the business.

Reach out to ³Ô¹Ï±¬ÁÏ Business Consulting to find out how you can use ³Ô¹Ï±¬ÁÏ Pulse data to identify the right KOLs and improve scientific engagement.

1, 2 U.S.-based analysis of migraine products using data from ³Ô¹Ï±¬ÁÏ Link, ³Ô¹Ï±¬ÁÏ OpenData, ³Ô¹Ï±¬ÁÏ Compass, and ³Ô¹Ï±¬ÁÏ Pulse, March 2019¨CJune 2023.
3, 4 U.S. ³Ô¹Ï±¬ÁÏ Pulse, ³Ô¹Ï±¬ÁÏ Link Key People data, April 2022¨CApril 2023.

Global and Regional Trends

This report highlights global and regional field engagement trends from ³Ô¹Ï±¬ÁÏ Pulse data between July 2022 and June 2023. ³Ô¹Ï±¬ÁÏ Pulse data is sourced from ³Ô¹Ï±¬ÁÏ¡¯s aggregated CRM activity dataset, inclusive of field engagement stats from all instances of ³Ô¹Ï±¬ÁÏ CRM globally. For the first time, this report also includes insights into global field medical trends.

Global field medical trends
Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Global field medical trends

Figure 1: Channel mix evolution, global field medical

Figure 2: Channel mix, global field medical


Global field medical activity Weekly activity per user by engagement channel

Figure 3: Activity by region, global field medical

Figure 4: Activity by company size, global field medical


Global field medical engagement quality Consolidation of key quality metrics

Figure 5: Approved email volume, global field medical

Figure 6: Content usage by channel, global field medical

Figure 7: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, global field medical

Global field medical trends
Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Global trends: all field roles

Figure 8: Channel mix evolution, global

Figure 9: Channel mix, global


Global field team activity Weekly activity per user by engagement channel

Figure 10: Activity by region, global

Figure 11: Activity by user type, global

Figure 12: Activity by company size, global


Global engagement quality Consolidation of key quality metrics

Figure 13: Approved email volume, global

Figure 14: Content usage by channel, global

Figure 15: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, global

Global field medical trends
Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

U.S. market trends

Figure 16: Channel mix evolution, U.S.

Figure 17: Channel mix, U.S.


U.S. field team activity Weekly activity per user by engagement channel

Figure 18: Activity, U.S.

Figure 19: Activity by user type, U.S.

Figure 20: Activity by company size, U.S.


U.S. engagement quality Consolidation of key quality metrics

Figure 21: Approved email volume, U.S.

Figure 22: Content usage by channel, U.S.

Figure 23: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, U.S.
Global field medical trends
Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Europe market trends

Figure 24: Channel mix evolution, Europe

Figure 25: Channel mix, Europe


Europe field team activity Weekly activity per user by engagement channel

Figure 26: Activity by country, EU5

Figure 27: Activity by user type, Europe

Figure 28: Activity by company size, Europe


Europe engagement quality Consolidation of key quality metrics

Figure 29: Approved email volume, Europe

Figure 30: Content usage by channel, Europe

Figure 31: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Europe

Global field medical trends
Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Asia market trends

Figure 32: Channel mix evolution, Asia

Figure 33: Channel mix, Asia


Asia field team activity Weekly activity per user by engagement channel

Figure 34: Activity by country, Asia

Figure 35: Activity by user type, Asia

Figure 36: Activity by company size, Asia


Asia engagement quality Consolidation of key quality metrics

Figure 37: Approved email volume, Asia

Figure 38: Content usage by channel, Asia

Figure 39: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Asia

Global field medical trends
Global trends
U.S. trends
Europe trends
Asia trends
Latin America trends

Latin America market trends

Figure 40: Channel mix evolution, Latin America

Figure 41: Channel mix, Latin America


Latin America field team activity Weekly activity per user by engagement channel

Figure 42: Activity by country, Latin America

Figure 43: Activity by user type, Latin America

Figure 44: Activity by company size, Latin America


Latin America engagement quality Consolidation of key quality metrics

Figure 45: Approved email volume, Latin America

Figure 46: Content usage by channel, Latin America

Figure 47: ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration, Latin America


Appendix: Data dictionary

Metric definitions

  • Channel mix evolution over time: Weekly ³Ô¹Ï±¬ÁÏ CRM activity volume broken down by the channel of engagement (in-person, phone, video, email, chat, or text)
  • Channel mix: Total ³Ô¹Ï±¬ÁÏ CRM activity volume broken down by engagement channel percentage
  • Weekly activities per user: The average weekly number of ³Ô¹Ï±¬ÁÏ CRM activities submitted per number of users active in ³Ô¹Ï±¬ÁÏ CRM
  • Approved email volume: Volume of approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • Email open rate: Percentage of approved emails opened at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • Email click rate: Percentage of approved emails clicked at least once out of all approved emails sent via ³Ô¹Ï±¬ÁÏ CRM
  • In-person % CLM usage: Percentage of in-person engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • Video % CLM usage: Percentage of video engagements that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • ³Ô¹Ï±¬ÁÏ CRM Engage meeting % CLM usage: Percentage of ³Ô¹Ï±¬ÁÏ CRM Engage meetings that leveraged content in ³Ô¹Ï±¬ÁÏ CRM
  • ³Ô¹Ï±¬ÁÏ CRM Engage meeting duration: The average duration of ³Ô¹Ï±¬ÁÏ CRM Engage meetings in minutes

Engagement channel definitions

  • In-person: Submitted calls with a CRM Standard Metrics call channel value of ¡®in-person¡¯
  • Phone: Submitted calls with a CRM Standard Metrics call channel value of ¡®phone¡¯
  • Video: ³Ô¹Ï±¬ÁÏ CRM Engage calls and video calls via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of ¡®video¡¯
  • Email: Approved emails and emails sent via other platforms that are then recorded as calls in ³Ô¹Ï±¬ÁÏ CRM with a Standard Metrics call channel value of ¡®email¡¯
  • Chat or text: Submitted calls with a CRM Standard Metrics call channel value of ¡®chat or text¡¯

User type definitions

  • Sales: Users that have been classified with the ¡®sales¡¯ value in the CRM Standard Metrics user type field
  • Key account manager: Users that have been classified with the ¡®key account manager¡¯ value in the CRM Standard Metrics user type field
  • Medical: Users that have been classified with the ¡®medical¡¯ value in the CRM Standard Metrics user type field
  • Top global biopharma: Top 17 global biopharma companies by revenue
  • Rest of industry: All other biopharmas

Region definitions

  • Global: All markets globally
  • Europe: Albania, Andorra, Armenia, Aruba, Austria, Azerbaijan, Belarus, Belgium, Bermuda, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, French Polynesia, Georgia, Germany, Greece, Greenland, Guadeloupe, Guernsey, Hungary, Ireland, Italy, Jersey, Latvia, Lithuania, Luxembourg, Macedonia, Malta, Martinique, Republic of Moldova, Monaco, Montenegro, Netherlands, New Caledonia, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
  • Asia: Australia, Bangladesh, Bhutan, Brunei Darussalam, Cambodia, Cocos (Keeling) Islands, Indonesia, Japan, Kazakhstan, Republic of Korea, Kyrgyzstan, Malaysia, Mongolia, Myanmar, Nauru, Nepal, New Zealand, Philippines, Samoa, Singapore, Solomon Islands, Sri Lanka, Taiwan, Tajikistan, Thailand, Turkmenistan, Uzbekistan, Vietnam
  • Latin America: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Trinidad and Tobago, Uruguay, Venezuela

Methodology

The ³Ô¹Ï±¬ÁÏ HCP 360 Trends Report is a quarterly industry benchmark for global and regional healthcare professional (HCP) engagement across the life sciences industry. The report is based on proprietary ³Ô¹Ï±¬ÁÏ Pulse data and insights from field engagement activities of more than 80% of all industry representatives worldwide (Asia Pacific, Europe, Latin America, and the United States). ³Ô¹Ï±¬ÁÏ CRM Standard Metrics ¡ª now used industrywide ¡ª provides the basis for consistent collection and measurement of engagement KPIs including channel mix and productivity across regions, roles, and market segments. The findings are based on:

  • Approximately 600 million annual global field activities captured in ³Ô¹Ï±¬ÁÏ CRM and ³Ô¹Ï±¬ÁÏ CRM Engage
  • 60 billion prescription (Rx) and medical (Mx) records captured in ³Ô¹Ï±¬ÁÏ Compass Patient, a U.S.-based granular patient data set
  • 3+ million profiles containing publications, clinical trials, conferences, associations, guidelines, grants, payments, social media, news mentions, and influence on community practice from ³Ô¹Ï±¬ÁÏ Link Key People across 85+ countries and 24 therapeutic areas
  • Global reference data of healthcare professionals, healthcare organizations, and affiliations from ³Ô¹Ï±¬ÁÏ OpenData, containing addresses, emails, specialties, demographics, and compliance data (license information and industry identifiers) available in 65+ countries today and 100+ countries by end of 2023

The ³Ô¹Ï±¬ÁÏ Pulse Field Trends Report delivers insights that inform the industry and help field teams align their strategy to key market trends for improved commercial success. The global ³Ô¹Ï±¬ÁÏ Business Consulting team also helps customers inform their strategies using industry benchmarking with ³Ô¹Ï±¬ÁÏ Pulse data.

³Ô¹Ï±¬ÁÏ Commercial Summit, Europe

Copenhagen | 18¨C19 November, 2026

Register Now
Let's Partner

Interested in learning more about
how ³Ô¹Ï±¬ÁÏ can help?

Contact Us Download PDF
Join the Conversation in ³Ô¹Ï±¬ÁÏ Connect

Where customers and ³Ô¹Ï±¬ÁÏ product leaders share information and ideas

³Ô¹Ï±¬ÁÏ Logo

Software, AI, Data, and Consulting for the Global Life Sciences Industry

? Copyright 2026 ³Ô¹Ï±¬ÁÏ Systems

Europe Headquarters

Follow Us on Social

Demo Center Contact ³Ô¹Ï±¬ÁÏ

Solutions

  • Clinical
  • Regulatory
  • Safety
  • Quality
  • Medical
  • Commercial
  • Industry Segments

Services

  • Business Consulting

Partners

Resources

  • Customers
  • Resources
  • Events
  • News & Press
  • Blog

About ³Ô¹Ï±¬ÁÏ

  • Leadership
  • Public Benefit Corporation
  • Corporate Citizenship
  • Diversity at ³Ô¹Ï±¬ÁÏ
  • Trust

European Headquarters

Follow Us on Social

Privacy Notice Terms Site Map